高级检索
当前位置: 首页 > 详情页

The regulatory effect of Xiaoyao San on glucocorticoid receptors under the condition of chronic stress.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of nephrology, Shenzhen Hospital of Chinese Medicine, Shenzhen 518033, Guangdong, China [2]Department of anesthesiology, Shenzhen Hospital of Chinese Medicine, Shenzhen 518033, Guangdong, China [3]South China Research Center for Acupuncture and Moxibustion, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, P.R. China
出处:
ISSN:

关键词: Xiaoyao San Chronic stress Glucocorticoid receptor HPA axis

摘要:
In modern society, fierce competitions cause yearly increase of depression and anxiety. Xiaoyao San is a traditional Chinese medicine which relieves depression and nourishes liver. The active ingredients contain saikoside A, saikoside C, saikoside D, ferulic acid, ligustilide, Atractylenolide I, Atractylenolide II, Atractylenolide Ⅲ, paeoniflorin, Albiflorin, liquiritin, glycyrrhizic acid and pachymic acid. In stress condition, glucocorticoid receptors participate in the hypothalamus-pituitarium-adrenal gland (HPA) axis to regulate the balance of organism. In response to stress, the HPA axis (hypothalamus-pituitarium-adrenal gland) is activated and the levels of glucocorticoid (GC) and catecholamine (CA) are increased to enhance neuroendocrine reactions. Chronic stress activates HPA axis and sustaining increase of GC, reduces the expression amount of GR and inhibits the mechanism of negative feedback on HPA. The lower negative feedback on HPA could lead to ketonemia. Several active ingredients of Xiaoyao San can raise the expression of GR and recover the negative feedback of HPA axis to relieve depression and illness state. In spite of the poor understanding of the current effective components in Xiaoyao San, this will be the focus of our further research. The study of Xiaoyao San could help us better understand its anti-depression mechanism and cure the patients.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 生物
小类 | 4 区 生化与分子生物学 4 区 细胞生物学
最新[2025]版:
第一作者:
第一作者机构: [1]Department of nephrology, Shenzhen Hospital of Chinese Medicine, Shenzhen 518033, Guangdong, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号